Anti-cancer therapies can cause severe sexual dysfunction, such as libido, body confidence, genital dysfunction and erectile dysfunction. Whilst these side effects can cause high levels of distress that impact partnered relationships, self-esteem and quality of life, they are not readily discussed by health professionals who are focused on concerns such as nausea, pain and fatigue. Patients want health professionals to discuss sex, sexuality and sexual health at diagnosis, during treatment and after treatment into survivorship, yet there are barriers to conversation, and consequently assessment, referral and documentation, such as confidence and comfort.
In this presentation A/Prof Safeera Hussainy will highlight the common sexual health side effects of anti-cancer therapies across tumour streams, their pharmacological management, and counselling tips for pharmacists and other health professionals using established person-centred communication frameworks.